Is there something else you would like to talk about- 15 months is a long time to raise the same question?
Its not the same question - details come out - (the fact of a BLA announcement being made yesterday introduced a PDUFA date that we didn't have before it came out - apart from that fact the announcement was essentially empty of new news) people vary in the level of detail they are interested in. Dachopper for instance can understand some of the science details sometimes that most other posters cannot or choose to see as irrelevant. But he doesn't stay on topic - he reads the room and performs for the room. So mostly the discussion never gets to the detail or to a level where disagreements get resolved.
The information you seek is currently with the FDA, the answer will be publicly available before August 3 2023.
The hell it is. This is the we are all ignorant and helpless and waiting together mantra that is so often put up.
A lot of the information I am seeking is in the public domain in science and stats papers where knowledge can be leveraged to make predictions on what is going to happen that MSB announcements will not contain.
Between now and the 2nd of August - this forum will contain heaps of posts to the effect of - gee isn't it frustrating to wait - but here we are waiting together (insert emoji).
Well fine - but it is also okay to have posts about the science and the technology - people don't want those - don't engage those. But don't personally attack - ignore.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-334
-
- There are more pages in this discussion • 674 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
96.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.087B |
Open | High | Low | Value | Volume |
98.0¢ | 98.5¢ | 95.0¢ | $2.395M | 2.483M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 19815 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
91.5¢ | 13260 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 57659 | 1.015 |
2 | 16901 | 1.010 |
7 | 43187 | 0.995 |
12 | 88418 | 0.990 |
4 | 5465 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
0.915 | 13260 | 4 |
0.920 | 6792 | 3 |
0.940 | 32066 | 3 |
0.945 | 24327 | 4 |
0.950 | 44854 | 10 |
Last trade - 15.59pm 13/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online